Zusammenfassung
Unter dem Begriff Osteoporose wird ein proportionaler Rückgang sowohl des Mineralgehaltes wie auch der Matrix des Knochens verstanden. Klinisch wird der Begriff Osteoporose aherdings viel großzügiger gehandhabt und auch für andere Zustände mit reduzierter Knochenmasse verwendet.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Aloia, J. F., Zanzi, I., Vaswani, A., EUis, K., Cohn, S. H.: Combination therapy for osteoporosis with estrogen, fluoride and calcium. J. Am. Geriatr. Soc. 30: 13–17 (1982).
Anonymous: Risk factors in postmenopausal osteoporosis. Lancet i: 1370–1372 (1985).
Antunes, C. M. F., Stolley, P. D., Rosenshein, N. B., Davies, J. L., Tonascia, J. A., Brown, C., Burnett, L., Rutledge, A., Pokempner, M., Garcia, R.: Endometrial cancer and estrogen use. New Engl. J. Med. 300: 9–13 (1979).
Avioh, L. v., McDonald, J. E., Lee, S. W.: The influence of age on the intestmal absorption of in women and its relation to 47Ca absorption in postmenopausal osteoporosis. J. Clin. Invest. 44: 1960–1967 (1965).
Baran, D. T., Teitelbaum, S. L., Bergfeld, M. A., Parker, G., Cmvant, E. M., Avioli, L. V.: Effect of alcohol ingestion on bone and mineral metabolism in rats. Am. J. Physiol. 238: 507–510 (1980).
Canalis, E. M., Dietrich, J. W., Maina, D. M., Raisz, L. G.: Hormonal control of bone collagen synthesis in vitro. Effects of insulin and glucagon. Endocrinology 100: 668–674 (1977).
Canalis, E.: Effect of insulin lüce growth factor I on DNA and protein synthesis in cultured rat calvaria. J. Clin. Invest. 66: 709–714 (1980).
Chestnut, C. H., Baylink, D. J., Sisom, K., Nelp, W. B., Roos, B. A.: Basal plasma immuno- reactive calcitonin in postmenopausal osteoporosis. Metabolism 29: 559–562 (1980).
Chestnut, C. H., Ivey, J. L., Gmber, H. E., Matthews, M., Nelp, W. B., Sisom, K., Baylink, D. J.: Stanozolol m postmenopausal osteoporosis: therapeutic efficacy and possible mechanisms of action. Metabolism 32: 571–580 (1983).
Christiansen, C., Christensen, M. S., Transbol, I.: Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy. Lancet i: 459–461 (1981).
Cohen, H. N., Farrah, D., Fogelman, I., Göll, C. C., Beastall, G. H., Mcintosh, W. B., Fletcher, M., Boyle, I. T.: A low dose regime of 1 -alpha-hydroxyvitamin D3 in the management of senile osteoporosis: a püot study. Clin. Endocrinol. 12: 537–542 (1980).
Cohn, S. H., Vaswani, A., Zanzi, L, Ellis, K. J.: Effect of aging on bone mass in adult women. Am. J. Physiol. 230: 143–148 (1976).
Compston, J. E., Chada, S., Merrett, A. L.: Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D. Brit. Med. J. 281: 910–911 (1980).
Council on Scientific Affairs: Estrogen replacement in the menopause. J.A.M.A. 249: 359–361 (1983).
Crilly, R. G., Jones, M. M., Horsman, A., Nordin, B. E. C.: Rise in plasma alkaline phosphatase at the menopause. Clin. Sci. 58: 341–342 (1980).
Dambacher, M. A., Ittner, J., Riiegsegger, P.: Neue Aspekte zur Pathogenese (und Therapie) der Osteoporose. Therapiewoche 35: 1879–1892 (1985).
Daniell, H. W.: Osteoporosis of the slender smoker. Arch. Int. Med. 136: 298–304 (1976).
Deftos, L. J., Weisman, M. H., Williams, G. W., Karpf, D. B., Frumar, A. M., Davidson, B. J., Parthemore, J. G., Judd, H. L.: Influence of age and sex on plasma calcitonin in human beings. New Engl. J.Med. 302: 1351–1353 (1980).
Dietrich, J. W., Canalis, E. M., Maina, D. M., Raisz, L. G.: Effect of glucocorticoids on fetal rat bone collagen synthesis in vitro. Endocrinology 104: 715–721 (1979).
Editorial: Osteoporosis and activity. Lancet i: 1365–1366 (1983).
Eilon, G., Raisz, L. G.: Comparison of the effects of stimulators and inhibitors of resorption on the release of lysosomal enzymes and radioactive calcium from fetal bone in organ culture. Endocrinology 103: 1969–1975 (1978).
Frumar, A. M., Meldrum, D. R., Geola, F., Shamoniki, I. M., Tataryn, I. V., Deftos, L. J., Judd, H. L.: Relationship of fasting urinary calcium to circulating estrogen and body weight in postmenopausal women. J. Clin. Endocrinol. Metabol. 50: 70–75 (1980).
Gallagher, J. C., Riggs, B. L., Eisman, J., Harmstra, A., Arnaud, S. B., DeLuca, H. F.: Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients. J. Clin. Invest. 64: 729–736 (1979).
Gallagher, J. C., Riggs, B. L., Jerpbak, C. M., Arnaud, C. D.: The effect of age on serum immunoreactive parathyroid hormone in normal and osteoporotic women. J. Lab. Clin. Med. 95: 373–385 (1980).
Goodman, C. E.: Osteoporosis: protective measures of nutrition and exercise. Geriatrics 40/4: 59–70 (1985).
Griffith, G. C., Nichols, G., Asher, J. D., Flanagan, B.: Heparin osteoporosis: J.M.A.A. 193: 91–94 (1965).
Heaney, R. P., Recker, R. R., Saville, P. D.: Menopausal changes in bone remodeling. J. Lab. Clin. Med. 92: 964–970 (1978).
Hoover, R., Gray, L. A., Cole, P., MacMahon, B.: Menopausal estrogens and breast cancer. New Engl. J. Med. 295: 401–405 (1976).
Horsman, A., Marshall, D. H., Nordin, B. E. C., Crilly, R. G., Simpson, M.: The relation between bone mass and calcium balance in women. Clin. Sci. 59: 137–142 (1980).
Horsman, A., Jones, M., Francis, R., Nordin, C.: The effect of estrogen dose on postmenopausal bone loss. New Engl. J. Med. 309: 1405–1407 (1983).
Hutchinson, T. A., Polansky, S. M., Feinstein, A. R.: Post-menopausal oestrogens protect against fractures of hip and distal radius. Lancet ii: 705–709 (1979).
Jaffe, M. D., Willis, P. W.: Multiple fractures associated with long-term sodium heparin therapy. J.A.M.A. 193: 158–150 (1965).
Jensen, J. S., Tondesvold, E.: Mortality after hip fractures. Acta Orthop. Scand. 50: 161–166 (1979).
Jowsey, J.: Why is mineral nutrition important in osteoporosis? Geriatrics 40/8: 39–48 (1978).
Jowsey, J., Riggs, B. L., Kelly, P. J., Hoffman, D. L.: Calcium and salmon calcitonin in treatment of osteoporosis. J. Clin. Endocrinol. Metabol. 47: 633–639 (1978).
Krolner, B., Nielsen, S. P.: Bone mineral content of the lumbar spine in normal and osteoporotic women: cross sectional and longitudinal studies. Clin. Sci. 62: 329–336 (1982).
Lane, J. M., Vigorita, V. J., Falls, M.: Osteoporosis: current diagnosis and treatment. Geriatrics 39/4:40–47 (1984).
Lewis, A. F.: Fracture of the neck of the femur: changing incidence. Brit. Med. J. 283: 1217–1220 (1981).
Lund, B., Sorensen, O. H., Lund, B., Agner, E.: Serum 1,25-Dihydroxyvitamin D in normal subjects and in patients with postmenopausal osteopenia. Influence of age, renal function and oestrogen therapy. Horm. Metabol. Res. 14: 271–274 (1982).
Marshall, D. H., Crilly, R. G., Nordin, B. E. C.: Plasma androstendione and oestrone levels in normal and osteoporotic postmenopausal women. Brit. Med. J. 2: 1177–1179 (1977).
McNair, P., Madsbad, S., Christiansen, C., Christensen, M. S., Faber, O. K., Binder, C., Transbol, I.: Bone loss in diabetes: effects of metabolic state. Diabetologia 17: 283–286 (1979).
Morimoto, S., Tsuji, M., Okada, Y., Onishi, T., Kumahara, Y.: The effect of oestrogens on human calcitonin secretion after calcium infusion in elderly female subjects. Chn. Endocrinol. 13: 135–143 (1980).
Mundy, G. R., Cove, D. H., Fisken, R.: Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet i: 1317–1320 (1980).
Nordin, B. E. C.: Clinical significance and pathogenesis of oestoporosis. Brit. Med. J. 1: 571–576 (1971).
Nordin, B. E. C., Horsman, A., CriUy, R. G., Marshall, D. H., Simpson, M.: Treatment of spinal osteoporosis in postmenopausal women. Brit. Med. J. 280: 451–454 (1980).
Pfeffer, R. I., Whipple, G. H., Kurosaki, T. T., Chapman, J. M.: Coronary risk and estrogen use in postmenopausal women. Am. J. Epidemiol. 107: 479–487 (1978).
Quigley, M. M., Hammond, C. B.: Estrogen replacement therapy — help or hazard? New Engl. J. Med. 301: 646–648 (1979).
Raisz, L. G., Canahs, E. M., Dietrich, J. W., Kream, B. E., Gworek, S. C.: Hormonal regulation of bone formation. Recent Progr. Horm. Res. 34: 335–356 (1978).
Raisz, L. G., Vanderhoek, J. Y., Simmons, H. A., Kream, B. E., Nicolaon, K. C.: Prostaglandin synthesis by fetal rat bone in vitro: evidence for a role of prostacyclin. Prostaglyndins 17: 905–911 (1979).
Raisz, L. G.: Osteoporosis. J. Am. Geriatr. Soc. 30: 127–138 (1982).
Recker, R. R., Saville, P. D., Heaney, R. P.: Effect of estrogens and calcium carbonate on bone loss in postmenopausal women. Ann. Int. Med. 87: 649–655 (1977).
Report from the Boston CoUabor. Drug Surveillance Program: Surgically confirmed gaU- bladder disease, venous thromboembohsm, and breast tumors in relation to postmenopausal estrogen therapy. New Engl. J. Med. 290: 15–19 (1974).
Riggs, B. L., Seeman, E., Hodgson, S. F., Taves, D. R., O’Fallon, W. M.: Effect of the fluoride/ calcium regimen on vertebral fracture occurrence in postmenopausal women. New Engl. J. Med. 306: 446–450 (1982).
Riggs, B. L., Melton, L. J.: Evidence for two distinct syndromes of involutional osteoporosis. Am. J. Med. 75: 899–901 (1983).
Slovik, D. M., Adams, J. S., Neer, R. M., Holick, M. F., Potts, J. T.: Deficient production of 1, 25-dihydroxyvitamin D in elderly osteoporotic patients. New Engl. J.Med. 305: 372–374 (1981).
Smith, D. M., Nance, W. E., Kang, K. W., Christian, J. C., Johnston, C. C.: Genetic factors in detemuningbone mass. J. Clin. Invest. 52: 2800 2808 (1973).
Stevenson, J. C., Abeyasekera, G., Hillyard, C. J., Phang, K. G., Maclntyre, I., Campbell, S., Townsend, P. T., Young, O., Whitehead, M. I.: Calcitonin and the calcium-regulating hormones in postmenopausal women: effect of oestrogens. Lancet i: 693–695 (1981).
Stewart, A. F., Adler, M., Byers, C. M., Segre, G. V., Broadus, A. E.: Calcium homeostasis in immobilization: an example of resorptive hypercalciura. NewEngl. J.Med. 306: 1136–1140 (1982).
Tibblin, S., Palsson, N., Rydberg, J.: Hyperparathyroidism in the elderly. Ann. Surg. 197: 135–138 (1983).
Tiegs, R. D., Body, J. J., Wahner, H. W., Barta, J., Riggs, B. L., Heath, H.: Calcitonin secretion in postmenopausal osteoporosis. New Engl. J. Med. 312: 1097–1100 (1985).
Toh, S. H., Claunch, B. C., Brown, F. H.: Effect of hyperthyroidism and its treatment on bone mineral content. Arch. Int. Med. 145: 883–886 (1985).
Weinstein, M. C.: Estrogen use in postmenopausal women — costs, risks, and benefits. New Engl. J. Med. 303: 308–316 (1980).
Wiedeman, E., Schwartz, E., Frantz, A. G.: Acute and chronic estrogen effects upon serum somatomedin activity, growth hormone and prolactin in man. J. Chn. Endocrinol. Metabol. 42:942–952 (1976).
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag/Wien
About this chapter
Cite this chapter
Tragl, K.H. (1986). Die Osteoporose. In: Internistische Geriatrie. Springer, Vienna. https://doi.org/10.1007/978-3-7091-8839-2_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-8839-2_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-81904-3
Online ISBN: 978-3-7091-8839-2
eBook Packages: Springer Book Archive